Sequoia Financial Advisors LLC boosted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 42.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 13,217 shares of the company’s stock after buying an additional 3,941 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in GE HealthCare Technologies were worth $1,240,000 as of its most recent SEC filing.
Other hedge funds have also recently bought and sold shares of the company. Plimoth Trust Co. LLC boosted its holdings in GE HealthCare Technologies by 73.6% in the third quarter. Plimoth Trust Co. LLC now owns 7,601 shares of the company’s stock valued at $713,000 after acquiring an additional 3,222 shares during the last quarter. Whittier Trust Co. of Nevada Inc. boosted its stake in shares of GE HealthCare Technologies by 2.6% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 74,115 shares of the company’s stock valued at $6,956,000 after purchasing an additional 1,879 shares during the last quarter. Whittier Trust Co. grew its position in shares of GE HealthCare Technologies by 4.7% during the 3rd quarter. Whittier Trust Co. now owns 121,569 shares of the company’s stock worth $11,409,000 after buying an additional 5,441 shares during the period. Koss Olinger Consulting LLC bought a new stake in shares of GE HealthCare Technologies during the third quarter worth approximately $241,000. Finally, Allspring Global Investments Holdings LLC lifted its holdings in GE HealthCare Technologies by 2.3% in the third quarter. Allspring Global Investments Holdings LLC now owns 24,693 shares of the company’s stock valued at $2,317,000 after buying an additional 562 shares during the period. 82.06% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at approximately $1,414,377.02. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.27% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
View Our Latest Stock Report on GE HealthCare Technologies
GE HealthCare Technologies Trading Down 0.5 %
GEHC opened at $88.42 on Friday. The stock has a market capitalization of $40.36 billion, a P/E ratio of 25.85, a P/E/G ratio of 3.39 and a beta of 1.18. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.05. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.55. The firm’s fifty day simple moving average is $88.42 and its 200 day simple moving average is $83.45.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The company had revenue of $4.84 billion during the quarter, compared to analysts’ expectations of $4.88 billion. During the same period in the prior year, the firm earned $0.92 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up .5% compared to the same quarter last year. As a group, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.26 EPS for the current fiscal year.
GE HealthCare Technologies Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.
GE HealthCare Technologies Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Further Reading
- Five stocks we like better than GE HealthCare Technologies
- Are Penny Stocks a Good Fit for Your Portfolio?
- Texas Roadhouse Stock Steering for New Highs This Year
- What is Forex and How Does it Work?
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- The Role Economic Reports Play in a Successful Investment Strategy
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.